Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures

被引：0
|
作者：
Raquel Costa
Bernhard Steinhoff
Helena Gama
Fábio Ikedo
José-Francisco Rocha
Patrício Soares-da-Silva
机构：
[1] BIAL-Portela & Cª,Department of Research and Development
[2] S.A.,Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine
[3] Epilepsy Center Kork,MedInUP
[4] University of Porto,Center for Drug Discovery and Innovative Medicines
[5] University of Porto,undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1109 / 1117
页数：8
相关论文
共 50 条
  • [41] Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial
    Aboumatar, Sami
    Krishnaiengar, Suparna R.
    Cantu, David
    Zhang, Yi
    Grinnell, Todd
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 225
  • [42] Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
    Gil-Nagel, A.
    Lopes-Lima, J.
    Almeida, L.
    Maia, J.
    Soares-da-Silva, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (05): : 281 - 287
  • [43] Safety and tolerability of adjunctive eslicarbazepine acetate in adolescents with focal-onset seizures: Data from three double-blind, placebo-controlled randomized clinical studies
    Garcia-Penas, Juan-Jose
    Ikedo, Fabio
    Fonseca, Miguel
    Fernandez, Guillermo Castilla
    Pereira, Ana
    Moreira, Joana
    Gama, Helena
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 159 - 160
  • [44] Eslicarbazepine acetate: A guide to its use as adjunctive therapy in partial-onset seizures
    Drugs & Therapy Perspectives, 2011, 27 (10) : 1 - 5
  • [45] THE ROME STUDY (RETROSPECTIVE OBSERVATIONAL MULTICENTER STUDY ON ESL): 'EFFICACY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE (ESL) AS ADJUNCTIVE THERAPY FOR ADULT PATIENTS WITH PARTIAL ONSET SEIZURES AND GLOBAL EFFECT ON QUALITY OF LIFE'
    Assenza, G.
    Mecarelli, O.
    Assenza, F.
    Tombini, M.
    Di Lazzaro, V
    Pulitano, P.
    EPILEPSIA, 2016, 57 : 186 - 186
  • [46] Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
    Villanueva, V.
    Serratosa, J. M.
    Guillamon, E.
    Garces, M.
    Giraldez, B. G.
    Toledo, M.
    Salas-Puig, J.
    Lopez Gonzalez, F. J.
    Flores, J.
    Rodriguez-Uranga, J.
    Castillo, A.
    Mauri, J. A.
    Camacho, J. L.
    Lopez-Gomariz, E.
    Giner, P.
    Torres, N.
    Palau, J.
    Molins, A.
    EPILEPSY RESEARCH, 2014, 108 (07) : 1243 - 1252
  • [47] Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies
    Brodie, Martin J.
    Whitesides, John
    Schiemann, Jimmy
    D'Souza, Joseph
    Johnson, Martin E.
    EPILEPSY RESEARCH, 2016, 127 : 114 - 118
  • [48] SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE TREATMENT IN ELDERLY PATIENTS
    Costa, R.
    Oliveira, C.
    Lopes, N.
    Gama, H.
    Sousa, R.
    Nunes, T.
    Soares-da-Silva, P.
    EPILEPSIA, 2014, 55 : 112 - 112
  • [49] A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures
    Rocamora, Rodrigo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (04) : 178 - 186
  • [50] ECONOMIC EVALUATION OF ADJUNCTIVE ESLICARBAZEPINE ACETATE IN PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES
    Philips, Z.
    Cope, S.
    Maclaine, G.
    Raper, S.
    EPILEPSIA, 2011, 52 : 255 - 255
12345